Protect your invention by filing a Provisional or Utility Patent Application using our software today! It’s easy and fully backed by patent lawyers â€“ and you don’t have to pay until you’re done.
The Moderna Therapeutics, Inc. patent solves the following problem:
There are many problems by way of effecting protein expression. For example, introduced DNA becomes integrated into the host cell genomic DNA at certain frequencies, resulting in alteration and / or damage to the host cell genomic DNA. Another, heterologous deoxyribonucleic acid (DNA) was introduced into a cell can be inherited in daughter cells (whether or not the heterologous DNA integrated into the chromosome) or by children.
Our analysis of this patent is as follows:
Moderna Therapeutics, Inc.’s patent US 9220755 B2 deals with Modified polynucleotides for the production of proteins associated with blood and lymphatic disorders.
The invention relates to compositions and methods for the preparation, performance and use of therapeutic polynucleotides, first transcripts and mmRNA molecules.
The revolutionary PowerPatent provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.